(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This volume represents a compendium of scientific findings and approaches to the study of angiogenesis in cancer. The second edition of Antiangiogenic Agents in Cancer Therapy is intended to give a current perspective on the state-of-the-art of angiogenensis and therapy directed at this process.
Antiangiogenesis is a dynamic and evolving field in oncology. New therapeutic targets continue to emerge followed by the rapid development of new therapeutic agents to be investigated in clinical trials. Optimizing the therapeutic potential of antiangiogenic agents in combination with the other therapies in the armamentarium to fight cancer will be an on-going challenge.
Contents:
Antiangiogenesis, 2nd edition Table of Contents Beverly A. Teicher and Lee M. Ellis, editors 1. The vascular endothelial growth factor family and its receptors. Daniel J. Hicklin 2. The cycle between angiogenesis, perfusion and hypoxia in tumors. Mark W. Dewhirst, Yiting Cao, Gordana Vlahovic 3. The role of integrins in tumor angiogenesis. Aparna R. Aiyer, Judith A. Varner 4. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways. Adam P. Dicker 5. Tumor endothelial cell abnormalities. Andrew C. Dudley, Michael Klagsbrun 6. The extracellular matrix and VEGF processing. Sunyoung Lee, M. Luisa Iruela-Arispe 7. Endothelial precursor cells. Rebecca G. Bagley 8. Role of pericytes in angiogenesis. Chunhua Lu, Anil K. Sood 9. VEGF in the adult: Implications for anti-VEGF therapies.Arindel S. R. Maharaj, Patricia D'Amore 10. Newer Vascular Targets. Beverly A. Teicher 11. Chemokines in Angiogenesis. Michael P. Keane, John A. Belperio, Robert M. Strieter 12. Angiopoietins and Tie receptors. Hanako Kobayashi, Laura M. DeBusk, P. Charles Lin 13. Imaging angiogenesis. Sanjeev P. Kalva, Saravanan Namasivayam, Dushyant Vasuedeo Sahani 14. VEGF and Tumor Vascular Structure. Yineng Fu, Ann M. Dvorak, Harold F. Dvorak 15. Lymphatic system in the pathology of cancer. Bronek Pytowski 16. Metronomic lo dose antiangiogenic chemotherapy in mice and man. Robert S. Kerbel, UEmmenegger, S Man, R Munoz, C Folkins, Y Shaked 17. Small molecule vascular disrupting agents in cancer therapy. Dietmar W. Siemann, Michael R. Horsman 18. Challenges in translating anti-angiogenic therapy from the bench to bedside. Lee M. Ellis, Nikolaos A. Dallas, George van Buren II, Sherry Lim, Ling Xia, Fan Fan, Michael J. Gray 19. Prognostic and predictive significance of surrogate biomarkers of angiogenesis. Raffaelo Longo, Francesco Torino, Giampietro Gasparini 20. Regulation of angiogenesis in cancer and its therapeutic implications. Liangfeng Han, Annaka M. Lorincz, Saraswati Sukumar 21. Angiogenesis and Angiogenesis inhibition in Sarcomas. Steven DuBois, George Demetri 22. Anti-angiogenesis agents in colorectal cancer. Axel Grothey 23. Antiangiogenic therapy for primary CNS tumors. Katherine E. Warren, Howard A. Fine 24. Angiogenesis inhibitors for the treatment of small cell and non-small cell lung cancer. Monique B. Nilsson, Emer O. Hanrahan, John V. Heymach 25. Anti-angiogenic therapy of renal carcinoma. Michael S. Gordon, Scot W. Ebbinghaus 26. Antiangiogenesis Therapies in Gynecological Malignancies. Robert A. Burger 27. Anti-angiogenic agents in myeloid malignancies. Magda Melchert, Alan F. List 28. Angiogenesis in malignant and non-malignant pediatric tumors. Domenico Ribatti, Mirco Ponzoni 29. Endpoints for the determination of efficacy of antiangiogenic agents in clinical trials. Joseph Paul Eder, Dan S. Zuckerman 30. The role of imaging
PRODUCT DETAILS
Publisher: Springer (Humana Press Inc.)
Publication date: December, 2007
Pages: 578
Weight: 1206g
Availability: Available
Subcategories: General Issues, Oncology, Oncology, Pathology, Pharmacology
From the same series
Nicola Curtin
Jorge J. Castillo
Moulay A. Alaoui-Jamali
Gail Lewis Phillips
Frank E. Koehn
Beverly A. Teicher
Gary J. Kelloff
Ryan J. Sullivan
Gary K Schwartz
Val R Adams
Antonio Tito Fojo
William D. Figg
Steven Kanner
Giovanni Melillo
Masaki Terabe
Yves Pommier
Derek LeRoith
Beverly A. Teicher
Ann L. Jackman
Jorge J. Castillo
Manuel Hidalgo
Vinata B. Lokeshwar
Beverly A. Teicher
Moulay A. Alaoui-Jamali
Saïd M. Sebti
Frank E. Koehn
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
Beverly A. Teicher
Alan M. Gewirtz
Michael A Morse
Janusz W. Rak
J. Silvio Gutkind
Maryann Foote
Zahid H. Siddik
L. Harivardhan Reddy
Gavin J. Gordon
Masaki Terabe
Yves Pommier
Derek LeRoith
Neil J. Clendeninn
Howard L. Kaufman
John D. Haley
Manuel Hidalgo
Beverly A. Teicher
Ulrike Stein
Pat Price
Kelly K. Hunt
Mary L. Disis
David A. Gewirtz
Beverly A. Teicher
Sayed S. Daoud
Nicholas P. Farrell
Vinata B. Lokeshwar
Beverly A. Teicher
Giampietro Gasparini
Doriano Fabbro
Nicholas B. La Thangue
David E. Fisher
Beverly A. Teicher
John A. Hickman
Godefridus J. Peters
Julian Adams
Sonia Jakowlew
Antonio Giordano
Youcef M. Rustum
Michel Page
Gurmit Singh
Gary J. Kelloff
Moulay A. Alaoui-Jamali
Wafik S. El-Deiry
Keiko Hiyama
Amy M. Fulton
Federico Innocenti
Hak Choy
Sonia Jakowlew
Dennis M. Brown
Michael T. Lotze
Randall E. Harris
Eric Verdin
Benjamin Bonavida
Rebecca G. Bagley
Vitaly A. Polunovsky
Benjamin Bonavida
L. Harivardhan Reddy
V. Craig Jordan
Zahid H. Siddik
Erwin G. van Meir
Amy M. Fulton
Beverly A. Teicher
Keiko Hiyama
Gavin J. Gordon
David S. Ettinger
Federico Innocenti
John D. Haley
Benjamin Bonavida
Antonio Tito Fojo
Sonia Jakowlew
Sonia Jakowlew
Howard L. Kaufman
David A. Gewirtz
Sayed S. Daoud
Pat Price
Michael T. Lotze
Ulrike Stein
Kelly K. Hunt
Godefridus J. Peters
Beverly A. Teicher
Eric Verdin